Search for: "Anda Pharmaceuticals, Inc"
Results 321 - 340
of 610
Sorted by Relevance
|
Sort by Date
17 Aug 2011, 3:00 pm
Endo Pharmaceuticals, Inc., C.A. [read post]
2 Dec 2013, 2:16 pm
Plaintiff Cadence Pharmaceuticals, Inc. [read post]
13 Mar 2013, 4:05 pm
Endo Pharmaceuticals Inc. v. [read post]
30 Mar 2007, 9:48 am
Genentech, Inc., 127 S. [read post]
26 Jun 2011, 8:59 pm
In 2008, Minrad, Inc. [read post]
15 Jul 2013, 8:50 pm
Teva Parenteral Medicines, Inc., et al., C.A. [read post]
24 Sep 2015, 11:31 am
Ivax Pharmaceuticals, Inc.,501 F.3d 1263 (Fed. [read post]
10 Feb 2011, 5:35 pm
Another, subsequent ANDA sponsor, Sun Pharmaceuticals, obtained tentative approval for its ANDA No. 78-433 on March 4, 2008. [read post]
29 Jul 2013, 12:16 pm
Mylan Pharmaceuticals Inc. et al., C.A. [read post]
18 Jan 2024, 9:16 am
Teva Pharmaceuticals USA, Inc., 7 F.4th 1320, 1333 (Fed. [read post]
1 Aug 2011, 8:19 am
The seven defendants, Actavis Elizabeth LLC, Sun Pharmaceuticals, Sandoz Inc., Mylan Pharmaceuticals, Apotex Inc., Aurobindo Pharma Ltd., and Teva Pharmaceuticals, had filed an Abbreviated New Drug Application (ANDA) seeking to utilize Lilly's patented formula and claiming invalidity of Lilly's patent, No. 5,658,590, Treatment of attention-deficit/hyperactivity disorder, which has been issued by the US Patent Office. [read post]
24 Aug 2011, 4:17 am
., Inc., No. 10 C 112 (N.D. [read post]
28 Sep 2012, 11:15 am
Watson Pharmaceuticals, Inc., No. 10-12729, where the Eleventh Circuit upheld reverse payments -- finding no antitrust violation in settlements involving generic Androgel. [read post]
26 May 2015, 12:53 pm
., Ltd. of Tokyo, Japan; Daiichi Sankyo, Inc. of Parsippany, New Jersey; and Ube Industries, Ltd of Yamaguchi, Japan filed a federal lawsuit in the Southern District of Indiana alleging that HEC Pharm USA, Inc. of Princeton, New Jersey and HEC Pharm Co. [read post]
5 Sep 2012, 5:45 pm
California - The Federal Circuit on Tuesday gave Santarus Inc. another chance to prove that its patents for the heartburn drug Zegerid are valid and that Par Pharmaceuticals Inc.'s proposed generic version would infringe those patents. [read post]
29 Apr 2015, 11:15 am
This lawsuit adds another two new Defendants, Lupin Ltd. and Lupin Pharmaceuticals, Inc. [read post]
5 Apr 2011, 2:35 pm
Par Pharmaceutical, Inc. [read post]
10 May 2012, 9:00 am
Gorbec Pharmaceutical Services, Inc. [read post]
5 Dec 2022, 6:55 am
In Teva Branded Pharmaceutical Products R&D, Inc. v. [read post]
5 Dec 2022, 6:55 am
In Teva Branded Pharmaceutical Products R&D, Inc. v. [read post]